Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma and Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05003895
What this trial is testing

GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerMetastatic Hepatocellular Carcinoma
National Cancer Institute (NCI) 38
Post-approval studies (Phase 4)Not Yet RecruitingNCT07668570
What this trial is testing

SBRT Plus QL1706 as Second-Line Therapy for Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Hebei Medical University Fourth Hospital 36
Not applicableActive Not RecruitingNCT06934070
What this trial is testing

Predictive Value of Albumin - Bilirubin Score and CRP - Albumin - Lymphocyte Index for HCC Prognosis After Radical Resection

Who this might be right for
Hepatocellular Carcinoma (HCC)Hepatocellular Carcinoma (HCC) Prognosis
Qiang Xu 287
Not applicableStudy completedNCT00883454
What this trial is testing

Estimation of Functional Liver Reserve Using Cholinesterases

Who this might be right for
Hepatocellular CarcinomaCirrhosisLiver Neoplasm+1 more
University of Milan 181
Early research (Phase 1)Active Not RecruitingNCT03860272
What this trial is testing

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

Who this might be right for
Advanced CancerAngiosarcomaColorectal Cancer Without Liver Metastases+5 more
Agenus Inc. 499
Not applicableUnknownNCT05557656
What this trial is testing

A Real World Study of Regogfinib in HCC

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 800
Large-scale testing (Phase 3)WithdrawnNCT02527772
What this trial is testing

Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University
Testing effectiveness (Phase 2)Study completedNCT00777894
What this trial is testing

Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Swiss Cancer Institute 18
Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT03963037
What this trial is testing

Characterization of Two Novel Mutations in the Apob Gene

Who this might be right for
Familial Hypobetalipoproteinaemia - Heterozygous FormLow-LDL-syndrome
Medical University Innsbruck 16
Not applicableStudy completedNCT00132041
What this trial is testing

Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis

Who this might be right for
Liver Cancer
American College of Radiology Imaging Network 51
Not applicableEnded earlyNCT04258566
What this trial is testing

Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies

Who this might be right for
Hepatocellular Carcinoma
National Institutes of Health Clinical Center (CC) 7
Not applicableStudy completedNCT02670122
What this trial is testing

Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 131
Testing effectiveness (Phase 2)Looking for participantsNCT06280105
What this trial is testing

A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With Apatinib

Who this might be right for
Hepatocellular Carcinoma
Meng Chao Hepatobiliary Hospital of Fujian Medical University 40
Not applicableActive Not RecruitingNCT05064553
What this trial is testing

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerHepatitis B+2 more
Exact Sciences Corporation 2,990
Early research (Phase 1)Study completedNCT03735628
What this trial is testing

Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Head and Neck Squamous Cell Carcinoma (HNSCC)Hepatocellular Carcinoma (HCC)
Bayer 16
Large-scale testing (Phase 3)Active Not RecruitingNCT05320692
What this trial is testing

TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 423
Testing effectiveness (Phase 2)Study completedNCT02509507
What this trial is testing

Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611

Who this might be right for
Hepatocellular CarcinomaLiver MetastasesCutaneous or Subcutaneous Lymph Node+1 more
Amgen 127
Testing effectiveness (Phase 2)Study completedNCT05104567
What this trial is testing

SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)

Who this might be right for
Oesophageal Squamous Cell CarcinomaGastric CancerHepatocellular Carcinoma+2 more
Sanofi 138
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07412054
What this trial is testing

Lenvatinib and Pembrolizumab With or Without BCAA in Unresectable HCC

Who this might be right for
HCC - Hepatocellular Carcinoma
Fudan University 234
Next Page